- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
EASL 2018 SAT-413
Dysfunctional surface antigen-specific memory B cells
accumulate in chronic hepatitis B infection
A. Burton1, L.J. Pallett2, L. Mccoy1, K. Suveizdyte1, O.E. Amin1, F. Froghi3,
B.R. Davidson3, U.S. Gill4, P.A. Blair5, C. Mauri5, N. Pelletier6,M. Maini1.
1UCL, Division of Infection and Immunity, London, United Kingdom;
2Division of Infection & Immunity, London, United Kingdom; 3UCL,
Institute of Liver and Digestive Health, London, United Kingdom; 4Barts
and the London, Centre for Immunobiology, London, United Kingdom;
5UCL, Division of Medicine, London, United Kingdom; 6Roche Innovation
Center, Roche Pharma and Early Research Development, Basel,
Switzerland
Email: [email protected]
Background and Aims: One important and under-researched
component of the natural control of hepatitis B (HBV) infection is
the development of antibodies against HBV surface antigen (HBsAg;
anti-HBs), which are a hallmark of functional cure. The production of
insufficient antibodies to neutralise the large quantities of circulating
HBsAg suggests there may be defects in the global and/or HBsAgspecific
memory B cell compartments.
Method: Using a novel bait reagent and 16-color flow cytometry, we
have comprehensively analysed the phenotype and function of global
and HBsAg-specific B cell subsets in a heterogeneous cohort of
patients with chronic HBV infection (CHB) and HBV-vaccinated
healthy controls.
Results: We show that HBsAg-specific B cells are detectable in CHB,
despite the lack of circulating anti-HBs antibodies in these patients.
However, in patients with CHB, HBsAg-specific memory B cells with
an atypical, dysfunctional phenotype (defined as CD27−CD21lo/−) are
expanded compared to vaccinated healthy controls. This population
expresses high levels of inhibitory receptors, and accordingly exhibits
impaired cytokine production, B cell receptor signaling and differentiation
into plasma cells compared to classical memory B cells.
Preliminary data suggest that immune complexes, known to circulate
in patients with chronic HBV infection, may further suppress B cell
receptor signaling through binding to inhibitory Fc-receptors
preferentially expressed on atypical memory B cells. Atypical
memory B cells with a dysfunctional phenotype are further enriched
within the HBV-infected liver, where they constitute a higher
proportion of the mature B cell pool than in healthy controls.
Conclusion: Overall, these data suggest that chronic antigen
exposure in CHB can drive dysfunction of HBsAg-specific B cells,
that may contribute to the failure of immune control.
|
|